Therapeutic potential of TGF-β inhibition in chronic renal failure

被引：35

作者：

Gagliardini, Elena ^{[1
]}

Benigni, Ariela ^{[1
]}

机构：

[1] Mario Negri Inst Pharmaceut Res, I-24125 Bergamo, Italy

来源：

EXPERT OPINION ON BIOLOGICAL THERAPY | 2007年 / 7卷 / 03期

关键词：

progressive nephropathies; proteinuria; renal fibrosis; transforming growth factor-beta;

D O I：

10.1517/14712598.7.3.293

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Chronic kidney diseases are emerging as a worldwide public health problem. The progression of kidney diseases closely correlates with the accumulation of extracellular matrix leading to glomerulosclerosis and tubulointerstitial injury. Transforming growth factor (TGF)-beta has been identified as a key mediator of kidney matrix accumulation. Overexpression of TGF-beta isoforms and their receptors was observed in a variety of renal diseases in both animals and humans. Given its crucial role in fibrotic kidney disease, TGF-beta has been recently considered as a possible target in the management of chronic renal diseases. This review discusses the role of TGF-beta in renal fibrosis and provides an overview of the strategies that, when interfering with TGF-beta expression and signalling, could be employed as new renoprotective treatments.

引用

页码：293 / 304

页数：12

共 50 条

[41] INHIBITION OF YAP BY VERTEPORFIN DECREASES TGF-β1 INDUCED RENAL FIBROBLAST ACTIVATION BY REGULATION OF TGF-β1/SMAD SIGNALING PATHWAY
Park, Sung Kwang
Jin, Jixiu
Ku, Jeong Sang
Park, Woong
Lee, Sik
Kim, Won
Kang, Kyungpyo
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
[42] TIMP-1 INHIBITION AMELIORATES RENAL FIBROSIS IN TGF-β TRANSGENIC MICE
Kokeny, Gabor
Fazekas, Krisztina
Rosivall, Laszlo
Mozes, Miklos M.
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 192 - 192
[43] Different impact on early arteriosclerosis by alteration of adiponectin (ADPN) and TGF-β1 in serum of children with chronic renal failure (CRF).
Zepf, KF
Voelker, C
Westphal, M
Mueller-Wiefel, DF
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 : 788A - 789A
[44] Renal allograft failure: can intragraft T cells activate latent TGF-β?
Pichitsiri, W.
Willet, J. D. P.
Jenkinson, S. E.
Ali, S.
Kirby, J. A.
IMMUNOLOGY, 2010, 131 : 116 - 116
[45] Decorin: a potential therapeutic candidate for ligamentum flavum hypertrophy by antagonizing TGF-β1
Wang, Shanxi
Qu, Yunkun
Fang, Xuan
Ding, Qing
Zhao, Hongqi
Yu, Xiaojun
Xu, Tao
Lu, Rui
Jing, Shaoze
Liu, Chaoxu
Wu, Hua
Liu, Yang
EXPERIMENTAL AND MOLECULAR MEDICINE, 2023, 55 (07): : 1413 - 1423
[46] Therapeutic potential of pharmacological TGF-β signaling pathway inhibitors in the pathogenesis of breast cancer
Khoshakhlagh, Mandieh
Soleimani, Atena
Binabaj, Maryam Moradi
Avan, Amir
Ferns, Gordon A.
Khazaei, Majid
Hassanian, Seyed Mandi
BIOCHEMICAL PHARMACOLOGY, 2019, 164 : 17 - 22
[47] Decorin: a potential therapeutic candidate for ligamentum flavum hypertrophy by antagonizing TGF-β1
Shanxi Wang
Yunkun Qu
Xuan Fang
Qing Ding
Hongqi Zhao
Xiaojun Yu
Tao Xu
Rui Lu
Shaoze Jing
Chaoxu Liu
Hua Wu
Yang Liu
Experimental & Molecular Medicine, 2023, 55 : 1413 - 1423
[48] ATRIOPEPTINS - CIRCULATING VOLUME REGULATORY HORMONES WITH POTENTIAL THERAPEUTIC ROLE IN CHRONIC-RENAL-FAILURE
COLE, BR
SCHWARTZ, D
MANNING, PT
KATSUBE, NC
NEEDLEMAN, P
JOURNAL OF HYPERTENSION, 1986, 4 : S13 - S16
[49] Therapeutic targeting of TGF-β in lung cancer
Aftabi, Sajjad
Behrooz, Amir Barzegar
Cordani, Marco
Rahiman, Niloufar
Sadeghdoust, Mohammadamin
Aligolighasemabadi, Farnaz
Pistorius, Stephen
Alavizadeh, Seyedeh Hoda
Taefehshokr, Nima
Ghavami, Saeid
FEBS JOURNAL, 2024,
[50] Targeting TGF-β Signaling for Therapeutic Gain
Akhurst, Rosemary J.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2017, 9 (10):

← 1 2 3 4 5 →